Pregnant women's blood is used in NIPT tests (noninvasive prenatal testing) to look for genetic anomalies in the fetus. For genetic diseases like Down syndrome, the DNA is analyzed. Conditions are not diagnosed by NIPT tests. They inform your doctor of the likelihood that a condition is present. Beginning at week ten of pregnancy, this test can be performed. Noninvasive prenatal testing is known as NIPT. It is a prenatal screening test used to determine whether the fetus is at risk of developing chromosomal disorders including Down syndrome, Edwards syndrome, or Patau syndrome. The test can also reveal the fetus's gender. It is carried out by drawing a sample of your blood, which also contains fetal DNA. The genetic makeup of the fetus can be seen by medical professionals thanks to the DNA that makes up a person's genes and chromosomes. A lab will examine the blood sample for particular congenital diseases. Not all chromosomal or genetic disorders can be detected by NIPT.
For more details please contact us at 8285108065.
